Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
The S&P/ASX 200 (INDEXASX:XJO) fell another 0.7% on Tuesday as OZ Minerals (ASX:OZL) and Resimac (ASX:RMC) shares made headlines.
Creso Pharma Ltd (ASX:CPH) was the second most-traded share on the ASX last week. With the share price up 1,000% in two weeks, is it too late to buy?
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 0.77% on Monday.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.08% at lunch.
Here are the headlines from the S&P/ASX 200 (INDEXASX: XJO)(ASX: XJO) and Australian finance circles on Tuesday morning, with Rio Tinto Limited’s (ASX: RIO) quarterly production guidance in focus.
The Australian share market or S&P/ASX 200 (INDEXASX: XJO)(ASX: XJO) index woke up on the right side of the bed and is expected to open slightly higher Friday morning, according to data from the Sydney Futures Exchange.
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO) has not had a good start to the day, it’s currently down almost 0.5%.
Shares of Cann Group Limited (ASX:CAN), Auscann Group Holdings Ltd (ASX:AC8), Creso Pharma Ltd (ASX:CPH), Stemcell United Ltd (ASX:SCU) and MMJ Phytotech Ltd (ASX:MMJ) have bounced on the Australian Government’s export approval.